精品文档---下载后可任意编辑30 例乳腺癌肝转移患者的临床分析和治疗评估的开题报告【摘要】目的：探讨乳腺癌肝转移的临床特点、诊断、治疗及预后，为临床治疗提供参考。方法：回顾性分析 30 例乳腺癌肝转移患者的临床资料，分析病理、影像学表现及治疗方式，并评估患者的预后情况。结果：30 例乳腺癌肝转移患者中，女性占 93.3%，男性占 6.7%。癌肿类型以浸润性导管癌和浸润性小叶癌为主。肝脏常表现为多处转移，肝外其他组织也常见转移。诊断主要以影像学和组织病理学为依据。治疗方案涵盖手术、放疗和化疗等多种形式。其中，化疗具有较好的疗效。患者的预后不良，中位生存期仅为 7 个月。结论：乳腺癌肝转移患者的预后不佳，应根据患者的具体情况，实行合理的治疗方案，选择化疗可能是一种较好的治疗方法。【关键词】 乳腺癌肝转移；临床特点；治疗；预后【Abstract】Objective: To investigate the clinical characteristics, diagnosis, treatment and prognosis of hepatic metastasis in breast cancer, and to provide reference for clinical treatment.Methods: Retrospectively analyzed the clinical data of 30 patients with hepatic metastasis in breast cancer, analyzed the pathological and imaging manifestations and treatment methods, and evaluated the prognosis of the patients.Results: Among the 30 cases of breast cancer liver metastasis, females accounted for 93.3% and males accounted for 6.7%. The types of tumors were mainly invasive ductal carcinoma and invasive lobular carcinoma. The liver is often characterized by multiple metastases, and metastases to other tissues outside the liver are also common. The diagnosis is mainly based on imaging and histopathology. The treatment plan covers various forms such as surgery, radiotherapy and chemotherapy. Among them, chemotherapy has a better curative effect. The prognosis of patients is poor, with a median survival time of only seven months.精品文档---下载后可任意编辑Conclusion: Patients with hepatic metastasis in breast cancer have poor prognosis. According to the specific situation of the patient, reasonable treatment options should be adopted, and chemotherapy may be a better treatment method.【Keywords】 Hepatic metastasis in breast cancer; Clinical characteristics; Treatment; Prognosis.
